Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-<svg     style="vertical-align:-4.698pt;width:13.15px;" id="M1" height="21.9375" version="1.1" viewBox="0 0 13.15 21.9375" width="13.15"  xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.022,-0,0,-.022,.062,16.025)"><path id="x1D6FD" d="M558 587q0 -32 -14 -61t-40 -53.5t-48.5 -41t-54.5 -36.5q144 -51 144 -174q0 -55 -43.5 -108t-104.5 -87q-77 -42 -131 -42q-31 0 -54 20t-31 47l11 18q48 -29 108 -29q79 0 119.5 43t40.5 109t-44.5 107.5t-119.5 50.5l22 47q34 1 65 21q96 61 96 157q0 42 -24 67.5
t-62 25.5q-24 0 -43.5 -9t-35 -29.5t-27 -44t-22.5 -63t-19.5 -75.5t-18.5 -91q-57 -294 -68 -380q-26 -190 -35 -200q-26 -31 -97 -37l-4 26q19 9 48 170l77 413q23 121 52.5 187.5t83.5 114.5q70 62 148 62q51 0 88.5 -34t37.5 -91z" /></g>

		
	
</svg>1) in Patients with Gastric Cancer

<table>NK cells cytotoxic activity (<i>∙</i>) and serum TGF-<svg height="13.425" id="M56" style="vertical-align:-2.29482pt" version="1.1" viewbox="0 0 8.8500004 13.425" width="8.8500004" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,13.425)">
<g transform="translate(72,-61.26)">
<text transform="matrix(1,0,0,-1,-71.95,63.6)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝛽</tspan>
</text>
</g>
</g>
</svg>1 levels (<span style="font-family:monospace">▴</span>) in patients with gastric cancer and healthy volunteers. Gastric cancer patients were divided into two groups: group 1 with stages I-II and group 2 with stages III-IV.</table>

BioMed Research International

fig2

Figure 2

Figure 2: Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-<svg     style="vertical-align:-4.698pt;width:13.15px;" id="M1" height="21.9375" version="1.1" viewBox="0 0 13.15 21.9375" width="13.15"  xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg">
	
		
			<g transform="matrix(.022,-0,0,-.022,.062,16.025)"><path id="x1D6FD" d="M558 587q0 -32 -14 -61t-40 -53.5t-48.5 -41t-54.5 -36.5q144 -51 144 -174q0 -55 -43.5 -108t-104.5 -87q-77 -42 -131 -42q-31 0 -54 20t-31 47l11 18q48 -29 108 -29q79 0 119.5 43t40.5 109t-44.5 107.5t-119.5 50.5l22 47q34 1 65 21q96 61 96 157q0 42 -24 67.5
t-62 25.5q-24 0 -43.5 -9t-35 -29.5t-27 -44t-22.5 -63t-19.5 -75.5t-18.5 -91q-57 -294 -68 -380q-26 -190 -35 -200q-26 -31 -97 -37l-4 26q19 9 48 170l77 413q23 121 52.5 187.5t83.5 114.5q70 62 148 62q51 0 88.5 -34t37.5 -91z" /></g>

		
	
</svg>1) in Patients with Gastric Cancer 

BioMed Research International

Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF- 1) in Patients with Gastric Cancer

Figure 2

Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-1) in Patients with Gastric Cancer